Koyfin Home > Directory > Health Care > Adverum Biotechnlgs > EBITDA Margin

Adverum Biotechnlgs EBITDA Margin Chart (ADVM)

Adverum Biotechnlgs annual/quarterly EBITDA Margin from 2013 to 2019. An EBITDA margin is a measurement of a company's earnings before interest, taxes, depreciation, and amortization as a percentage of its total revenue.
  • Adverum Biotechnlgs EBITDA Margin for the quarter ending September 09, 2019 was $-6,684m a 41.54% decrease of -2,777m year over year
  • Adverum Biotechnlgs EBITDA Margin for the last 12 months ending June 06, 2020 was $-35,072m a 48.10% decrease of -16,871m year over year
  • Adverum Biotechnlgs Annual EBITDA Margin for 2019 was $-26,789m a 83.48% decrease of -22,364m from 2018
  • Adverum Biotechnlgs Annual EBITDA Margin for 2018 was $-4,425m a 31.86% decrease of -1,410m from 2017
  • Adverum Biotechnlgs Annual EBITDA Margin for 2017 was $-3,015m a -8.42% increase of 254m from 2016
Other Margins & Efficiency Metrics:
  • Adverum Biotechnlgs Return on Capital % for the quarter ending September 09, 2018 was -20.57 a -10.43% increase of 2.15 year over year
  • Adverum Biotechnlgs Return on Equity % for the quarter ending September 09, 2018 was -37.34 a 13.20% decrease of -4.93 year over year
View Chart On Koyfin

Quarterly ADVM EBITDA Margin Data

09/2019$-6,684m
12/2018$-23,386m
09/2018$-2,186m
06/2018$-3,907m
03/2018$-8,096m
12/2017$-3,057m
09/2017$-3,031m
06/2017$-2,495m
03/2017$-3,262m
12/2016$-2,398m

Annual ADVM EBITDA Margin Data

2019$-26,789m
2018$-4,425m
2017$-3,015m
2016$-3,269m
2015$-1,813m
2014$-4,238m
2013$-548m
2012$-6,050m